Canada markets closed

Aadi Bioscience, Inc. (AADI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9100-0.0050 (-0.26%)
At close: 04:00PM EDT
1.9000 -0.01 (-0.52%)
After hours: 04:42PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 47.02M
Enterprise Value -40.09M
Trailing P/E 1.89
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.16
Price/Book (mrq)0.52
Enterprise Value/Revenue 3.48
Enterprise Value/EBITDA -0.62

Trading Information

Stock Price History

Beta (5Y Monthly) 0.35
52-Week Change 3-76.54%
S&P500 52-Week Change 326.49%
52 Week High 38.6000
52 Week Low 31.5500
50-Day Moving Average 32.0125
200-Day Moving Average 33.4305

Share Statistics

Avg Vol (3 month) 3333.17k
Avg Vol (10 day) 3177.5k
Shares Outstanding 524.55M
Implied Shares Outstanding 624.62M
Float 815.96M
% Held by Insiders 110.81%
% Held by Institutions 154.19%
Shares Short (Apr 30, 2024) 41.13M
Short Ratio (Apr 30, 2024) 45.82
Short % of Float (Apr 30, 2024) 46.81%
Short % of Shares Outstanding (Apr 30, 2024) 44.60%
Shares Short (prior month Mar 28, 2024) 4943.07k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Aug 27, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -288.72%
Operating Margin (ttm)-364.51%

Management Effectiveness

Return on Assets (ttm)-33.11%
Return on Equity (ttm)-58.22%

Income Statement

Revenue (ttm)23.84M
Revenue Per Share (ttm)0.88
Quarterly Revenue Growth (yoy)-8.80%
Gross Profit (ttm)N/A
EBITDA -74.44M
Net Income Avi to Common (ttm)-68.83M
Diluted EPS (ttm)-2.5400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)88.27M
Total Cash Per Share (mrq)3.6
Total Debt (mrq)1.16M
Total Debt/Equity (mrq)1.29%
Current Ratio (mrq)5.16
Book Value Per Share (mrq)3.68

Cash Flow Statement

Operating Cash Flow (ttm)-58.01M
Levered Free Cash Flow (ttm)-35.58M